This month, Nucleic Acid Insights concentrates on emerging modalities in the oligonucleotide therapeutics space, including a focus on the relationship between sequence and chemistry and how that impacts the properties of novel oligo-based medicines. In addition, we place a spotlight on the potential of cutting-edge extracellular vesicle delivery platforms to open up new opportunities for the nucleic acid therapeutics field.